Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Infectious Diseases
Published in: BMC Infectious Diseases 1/2020

01-12-2020 | Tick | Research article

Severe fever with thrombocytopenia syndrome: a systematic review and meta-analysis of epidemiology, clinical signs, routine laboratory diagnosis, risk factors, and outcomes

Authors: Zhiquan He, Bohao Wang, Yi Li, Yanhua Du, Hongxia Ma, Xingle Li, Wanshen Guo, Bianli Xu, Xueyong Huang

Published in: BMC Infectious Diseases | Issue 1/2020

Login to get access

Abstract

Background

Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease with the high case-fatality rate, and lack of vaccines. We aimed to systematically analysed the epidemiological characteristics, clinical signs, routine laboratory diagnosis, risk factors, and outcomes.

Methods

Documents on SFTS were collected by searching the Chinese National Knowledge Infrastructure, Wan Fang Data, PubMed, Embase, and Web of Science databases from 2011 to 2018. Meta-analysis was performed by using Review Manager and Stata software.

Results

Twenty-five articles involving 4143 cases were included. Diarrhea (odds ratio (OR) =1.60, 95% confidence interval (CI): 1.06 to 2.42, P = 0.02), and vomiting (OR = 1.56, 95% CI: 1.01 to 2.39, P = 0.04) on admission were associated with the fatal outcomes of SFTS. Compared to patients with mild symptoms, patients with severe symptoms had significantly elevated levels of lactic acid dehydrogenase (standard mean difference (SMD) =1.27, 95% CI: 0.59 to 1.94), alanine aminotransferase (SMD = 0.55, 95% CI: 0.24 to 0.85), aspirate aminotransferase (SMD = 1.01, 95% CI: 0.69 to 1.32), and creatine kinase (SMD = 1.04, 95% CI: 0.74 to 1.33) but had reduced platelet counts (SMD = -0.87, 95% CI: − 1.16 to − 0.58) and albumin levels (SMD = -1.00, 95% CI: − 1.32 to − 0.68). The risk factors for poor prognosis included age (mean difference (MD) =6.88, 95% CI: 5.41 to 8.35) and farming (OR = 2.01, 95% CI: 1.06 to 3.80). For the risk factors of contracting SFTS, the incidence of SFTS related to tick bites was 24% [95% CI: 0.18 to 0.31]. The pooled case-fatality rate of SFTS patients was 18% [95% CI: 0.16 to 0.21].

Conclusions

China is the country with the highest incidence of SFTS. May to July was the peak of the epidemic, and farmers were a high-risk group. The risk factor for SFTS included age (poor prognosis) and tick bites (contracting SFTS). Patients with severe diarrhea and vomiting symptoms on admission should be noted. Clinicians could use routine laboratory parameters and clinical symptoms as references for clinically suspected cases, classification of SFTS, and timely treatment, especially in basic hospitals.
Appendix
Available only for authorised users
Literature
1.
Yu XJ, Liang MF, Zhang SY, Liu Y, Li JD, Sun YL, et al. Fever with thrombocytopenia associated with a novel bunyavirus in China. N Engl J Med. 2011;364(16):1523–32.PubMedPubMedCentral
2.
Zhang YZ, Zhou DJ, Xiong Y, Chen XP, He YW, Sun Q, et al. Hemorrhagic fever caused by a novel tick-borne bunyavirus in Huaiyangshan, China. Chin J Epidemiol. 2011;32(3):209–20.
3.
Xu BL, Liu LC, Huang XY, Ma H, Zhang Y, Du YH, et al. Metagenomic analysis of fever, thrombocytopenia and leukopenia syndrome (FTLS) in Henan Province, China: discovery of a new bunyavirus. PLoS Pathog. 2011;7(11):e1002369.PubMedPubMedCentral
4.
Huang XY, Hu XN, Ma H, Du YH, Ma HX, Kang K, et al. Detection of new bunyavirus RNA by reverse transcription-loop-mediated isothermal amplification. J Clin Microbiol. 2014;52(2):531–5.PubMedPubMedCentral
5.
Zhu N, Tang WP, Cheng MJ, Shi XT. Advances in severe fever with thrombocytopenia syndrome (SFTS) and SFTS virus. China Trop Med. 2018;18(3):282–8.
6.
Liu K, Zhou H, Sun RX, Yao HW, Wang LP, Mu D, et al. A national assessment of the epidemiology of severe fever with thrombocytopenia syndrome, China. Sci Rep. 2015;5:9679.PubMedPubMedCentral
7.
Takahashi T, Maeda K, Suzuki T, Ishido A, Shigeoka T, Tominaga T, et al. The first identification and retrospective study of severe fever with thrombocytopenia syndrome in Japan. J Infect Dis. 2014;209(6):816–27.PubMed
8.
Kim KH, Yi J, Kim G, Choi SJ, Jun KI, Kim NH, et al. Severe fever with thrombocytopenia syndrome, South Korea, 2012. Emerg Infect Dis. 2013;19(11):1892–4.PubMedPubMedCentral
9.
Luo LM, Zhao L, Wen HL, Zhang ZT, Liu JW, Fang LZ, et al. Haemaphysalis longicornis ticks as reservoir and vector of severe fever with thrombocytopenia syndrome virus in China. Emerg Infect Dis. 2015;21(10):1770–6.PubMedPubMedCentral
10.
Zhuang L, Sun Y, Cui XM, Tang F, Hu JG, Wang LY, et al. Transmission of severe fever with thrombocytopenia syndrome virus by haemaphysalis longicornis ticks, China. Emerg Infect Dis. 2018;24(5):868–71.PubMedCentral
11.
Tang XY, Wu WL, Wang HF, Du YH, Liu LC, Kang K, et al. Human-to-human transmission of severe fever with thrombocytopenia syndrome bunyavirus through contact with infectious blood. J Infect Dis. 2013;207(5):736–9.PubMed
12.
Jung IY, Choi W, Kim J, Wang E, Park SW, Lee WJ, et al. Nosocomial person-to-person transmission of severe fever with thrombocytopenia syndrome. Clin Microbiol Infect. 2019;25(5):633.e1–4.
13.
Zhan J, Wang Q, Cheng J, Hu B, Li J, Zhan F, et al. Current status of severe fever with thrombocytopenia syndrome in China. Virol Sin. 2017;32(1):51–62.PubMedPubMedCentral
14.
15.
Saijo M. Severe fever with thrombocytopenia syndrome: epidemiology, pathophysiology, and development of specific treatement and prevention measures. Rinsho Ketsueki. 2018;59(10):2255–9.PubMed
16.
Giang HTN, Banno K, Minh LHN, Trinh LT, Loc LT, Eltobgy A, et al. Dengue hemophagocytic syndrome: a systematic review and meta-analysis on epidemiology, clinical signs, outcomes, and risk factors. Rev Med Virol. 2018;28(6):e2005.PubMed
17.
Hozo SP, Djulbegovic B, Hozo I. Estimating the mean and variance from the median, range, and the size of a sample. BMC Med Res Methodol. 2005;5:13.PubMedPubMedCentral
18.
Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135.PubMedPubMedCentral
19.
Luo D, Wan X, Liu J, Tong T. Optimally estimating the sample mean from the sample size, median, mid-range, and/or mid-quartile range. Stat Methods Med Res. 2018;27(6):1785–805.PubMed
20.
21.
Stuck AE, Rubenstein LZ, Wieland D, Egger M, Davey SG, Schneider M, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1998;316(7129):469.PubMedPubMedCentral
22.
Bao CJ, Wang H, Qi X, Hu JL, Zhou MH, Varma JK, et al. A family cluster of infections by a newly recognized bunyavirus in eastern China, 2007: further evidence of person-to-person transmission. Clin Infect Dis. 2011;53(12):1208–14.PubMed
23.
Deng B, Zhang S, Geng Y, Zhang Y, Wang Y, Yao W, et al. Cytokine and chemokine levels in patients with severe fever with thrombocytopenia syndrome virus. PLoS One. 2012;7(7):e41365.PubMedPubMedCentral
24.
Gai ZT, Zhang Y, Liang MF, Jin C, Zhang S, Zhu CB, et al. Clinical progress and risk factors for death in severe fever with thrombocytopenia syndrome patients. J Infect Dis. 2012;206(7):1095–102.PubMed
25.
Zhang YZ, He YW, Dai YA, Xiong YW, Zheng H, Zhou DJ, et al. Hemorrhagic fever caused by a novel bunyavirus in China: pathogenesis and correlates of fatal outcome. Clin Infect Dis. 2012;54(4):527–33.PubMed
26.
Deng BC, Zhou B, Zhang SJ, Zhu Y, Han LP, Geng YZ, et al. Clinical features and factors associated with severity and fatality among patients with severe fever with thrombocytopenia syndrome bunyavirus infection in Northeast China. PLoS One. 2013;8(11):e80802.PubMedPubMedCentral
27.
Sun L, Hu Y, Niyonsaba A, Tong Q, Lu L, Li H, et al. Detection and evaluation of immunofunction of patients with severe fever with thrombocytopenia syndrome. Clin Exp Med. 2014;14(4):389–95.PubMed
28.
Ding YP, Liang MF, Ye JB, Liu QH, Xiong CH, Long B, et al. Prognostic value of clinical and immunological markers in acute phase of SFTS virus infection. Clin Microbiol Infect. 2014;20(11):O870–8.PubMed
29.
Sun J, Chai C, Lv H, Lin J, Wang C, Chen E, et al. Epidemiological characteristics of severe fever with thrombocytopenia syndrome in Zhejiang Province, China. Int J Infect Dis. 2014;25:180–5.PubMed
30.
Xu Z, Cui N, Chen WW, Qin EQ, Nie WM, Yuan C, et al. Clinical characteristics in 422 patients with severe fever with thrombocytopenia syndrome. Infect Dis Info. 2015;28(1):28–32.
31.
Shin J, Kwon D, Youn SK, Park JH. Characteristics and factors associated with death among patients hospitalized for severe fever with thrombocytopenia syndrome, South Korea, 2013. Emerg Infect Dis. 2015;21(10):1704–10.PubMedPubMedCentral
32.
Choi SJ, Park SW, Bae IG, Kim SH, Ryu SY, Kim HA, et al. Severe fever with thrombocytopenia syndrome in South Korea, 2013-2015. PLoS Negl Trop Dis. 2016;10(12):e0005264.PubMedPubMedCentral
33.
Kato H, Yamagishi T, Shimada T, Matsui T, Shimojima M, Saijo M, et al. Epidemiological and clinical features of severe fever with thrombocytopenia syndrome in Japan, 2013–2014. PLoS One. 2016;11(10):e0165207.PubMedPubMedCentral
34.
Peng C, Wang H, Zhang W, Zheng X, Tong Q, Jie S, et al. Decreased monocyte subsets and TLR4 mediated functions in patients with acute severe fever with thrombocytopenia syndrome (SFTS). Int J Infect Dis. 2016;43:37–42.PubMed
35.
Xiong S, Zhang W, Li M, Xiong Y, Li M, Wang H, et al. A simple and practical score model for predicting the mortality of severe fever with thrombocytopenia syndrome patients. Medicine. 2016;95(52):e5708.PubMedPubMedCentral
36.
Xu HR, Zhao H. Analysis on surveillance data of severe fever with thrombocytopenia syndrome in Jinan City in 2011-2015. Modern Prev Med. 2016;43(18):3419–22.
37.
Zhao HY, Sun J, Yan XM, Xiong YL, Huang R, Zhang YY, et al. Clinical characteristics and risk factors for mortality of patients with severe fever with thrombocytopenia syndrome. Chin J Infect Dis. 2016;34(1):15–8.
38.
Zhang W, Li M, Xiong S, Wang H, Xiong Y, Li M, et al. Decreased myeloid dendritic cells indicate a poor prognosis of severe fever with thrombocytopenia syndrome patients. Int J Infect Dis. 2017;54:113–20.PubMed
39.
Hu J, Li Z, Hong L, Bao C, Zhang Z, Zhang H, et al. Preliminary fast diagnosis of severe fever with thrombocytopenia syndrome with clinical and epidemiological parameters. PLoS One. 2017;12(7):e0180256.PubMedPubMedCentral
40.
Hu J, Li S, Zhang X, Zhao H, Yang M, Xu L, et al. Correlations between clinical features and death in patients with severe fever with thrombocytopenia syndrome. Medicine. 2018;97(22):e10848.PubMedPubMedCentral
41.
Jia B, Wu W, Huang R, Wang G, Song P, Li Y, et al. Characterization of clinical features and outcome for human-to-human transmitted severe fever with thrombocytopenia syndrome. Infect Dis. 2018;50(8):1–8.
42.
Song YH, Sun ML, Wen KY. Epidemiological analysis on cases of severe fever with thrombocytopenia syndrome in Chaohu City, 2011-2017. Anhui J Prev Med. 2018;24(3):184–7.
43.
Xia GM, Zou GZ, Ye J, Gao YF, Li F, Jin L. Clinical characteristics and prognostic factors of fever with thrombocytopenia syndrome in Anhui Province. Anhui J Med. 2018;39(7):854–7.
44.
Li H, Lu QB, Xing B, Zhang S, Liu K, Du J, et al. Epidemiological and clinical features of laboratory-diagnosed severe fever with thrombocytopenia syndrome in China, 2011–17: a prospective observational study. Lancet Infect Dis. 2018;18(10):1127–37.PubMed
45.
Kwon JS, Kim MC, Kim JY, Jeon NY, Ryu BH, Hong J, et al. Kinetics of viral load and cytokines in severe fever with thrombocytopenia syndrome. J Clin Virol. 2018;101:57–62.PubMedPubMedCentral
46.
Xu X, Sun Z, Liu J, Zhang J, Liu T, Mu X, et al. Analysis of clinical features and early warning indicators of death from severe fever with thrombocytopenia syndrome. Int J Infect Dis. 2018;73:43–8.PubMed
47.
Kahlon SS, Peters CJ, Leduc J, Muchiri EM, Muchiri S, Njenga MK, et al. Severe rift valley fever may present with a characteristic clinical syndrome. Am J Trop Med Hyg. 2010;82(3):371–5.PubMedPubMedCentral
48.
Deshwal R, Qureshi MI, Singh R. Clinical and laboratory profile of dengue fever. J Assoc Physicians India. 2015;63(12):30–2.PubMed
49.
Ma T, Xie GX, Xu Q, Hong L, Zhang Z, Feng LJ, et al. Epidemiological characteristics of hemorrhagic fever with renal syndrome, Nanjing, 2011-2016. Modern Prev Med. 2017;44(23):4231–7.
50.
51.
Yuan YM, Cui N, Yuan C. Recommendations for nomenclature, clinical staging and typing of severe fever with thrombocytopenia syndrome. Chin J Infect Dis. 2016;34(1):57–8.
52.
Liu S, Chai C, Wang C, Amer S, Lv HK, He HX, et al. Systematic review of severe fever with thrombocytopenia syndrome: virology, epidemiology, and clinical characteristics. Rev Med Virol. 2014;24(2):90–102.PubMed
53.
Chen Y, Jia B, Liu Y, Huang R, Chen JH, Wu C, et al. Risk factors associated with fatality of severe fever with thrombocytopenia syndrome: a meta-analysis. Oncotarget. 2017;8(51):89119–29.PubMedPubMedCentral
54.
Liu MM, Lei XY, Yu XJ. Meta-analysis of the clinical and laboratory parameters of SFTS patients in China. Virol J. 2016;13(1):198.PubMedPubMedCentral
Metadata
Title
Severe fever with thrombocytopenia syndrome: a systematic review and meta-analysis of epidemiology, clinical signs, routine laboratory diagnosis, risk factors, and outcomes
Authors
Zhiquan He
Bohao Wang
Yi Li
Yanhua Du
Hongxia Ma
Xingle Li
Wanshen Guo
Bianli Xu
Xueyong Huang
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Infectious Diseases / Issue 1/2020
Electronic ISSN: 1471-2334
DOI
https://doi.org/10.1186/s12879-020-05303-0

Other articles of this Issue 1/2020

BMC Infectious Diseases 1/2020 Go to the issue

Research article

Toll-like receptor 2 downregulation and cytokine dysregulation predict mortality in patients with Staphylococcus aureus bacteremia

Research article

Adherence to World Health Organisation guidelines for treatment of early onset neonatal sepsis in low-income settings; a cohort study in Nepal

Research article

Adverse events in Chinese human immunodeficiency virus (HIV) patients receiving first line antiretroviral therapy

Research article

Can metagenomic next-generation sequencing identify the pathogens responsible for culture-negative prosthetic joint infection?

Research article

Revealing two dynamic dengue epidemic clusters in Thailand

Research article

Spatio-temporal analysis of socio-economic characteristics for pulmonary tuberculosis in Sichuan province of China, 2006–2015
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits